Showing results (181-190 of 355) with videos related to

Sort By:
Pageof 36
Circulation|March 5, 2023
Effect of Electronic Nudges on Influenza Vaccination Rate in Older Adults With Cardiovascular Disease: Prespecified Analysis of the NUDGE-FLU TrialDaniel Modin, Niklas Dyrby Johansen, Muthiah Vaduganathan, et al.
JAMA Cardiology|August 13, 2025
Efficacy and Tolerability of Finerenone According to the Use and Dosage of Diuretics: A Prespecified Analysis of the FINEARTS-HF Randomized Clinical TrialMisato Chimura, Pardeep S Jhund, Alasdair D Henderson, et al.
American Heart Journal|March 9, 2024
Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2: Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza seasonNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
The American Journal of Cardiology|April 19, 2026
Efficacy of Aficamten in Hypertrophic Cardiomyopathy Patients With Very-High Left Ventricular Outflow Tract GradientsJosef Veselka, Ramon Gimeno, Theodore P Abraham, et al.
European Journal of Heart Failure|October 3, 2025
Interplay of serum potassium and kidney function with finerenone in heart failure with mildly reduced or preserved ejection fraction: Findings from FINEARTS-HFJoão Pedro Ferreira, Muthiah Vaduganathan, Brian L Claggett, et al.
JAMA Cardiology|October 3, 2022
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical TrialMuthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.
JAMA|October 11, 2024
Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases: A Randomized Clinical TrialNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
JAMA Cardiology|March 28, 2026
EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HFMisato Chimura, Kirsty McDowell, Pardeep S Jhund, et al.
JACC. Heart Failure|April 10, 2025
Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF TrialJohn W Ostrominski, Finnian R Mc Causland, Brian L Claggett, et al.
European Heart Journal|April 21, 2017
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trialsAzmil H Abdul-Rahim, Ana-Cristina Perez, Rachael L MacIsaac, et al.
Pageof 36